Exponent Q2 Earnings Fall, Revenue Rises-May 2024-www.financetom.com

Exponent Q2 Earnings Fall, Revenue Rises

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Exponent Q2 Earnings Fall, Revenue Rises

Jul 31, 2025 3:20 PM

05:58 PM EDT, 07/31/2025 (MT Newswires) -- Exponent (EXPO) reported Q2 earnings late Thursday of $0.52 per diluted share, down from $0.57 a year earlier.

Three analysts polled by FactSet expected $0.49.

Revenue for the quarter ended July 4 was $142 million, up from $140.5 million a year earlier.

One analyst surveyed by FactSet expected $140.1 million.

The company reiterated its full-year 2025 guidance and expects Q3 revenue growth before reimbursements in the mid-single digits.

Separately, the company said it maintained its quarterly dividend at $0.30 per share, payable Sept. 19 to holders of record Sept. 5.

Previous page： Form 8.3 Next page： Form 8.3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3

Apr 6, 2026

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

Form 8.3

Apr 6, 2026

LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

Silo Pharma (SILO) Stock Soars 47% After European Patent Win: What You Should Know

Apr 6, 2026

Silo Pharma Inc. ( SILO ) shares surged 47.55% in after-hours trading Monday to $0.52 following a key intellectual property update tied to its PTSD treatment pipeline. Patent Development On Monday, the company said the European Patent Office issued a Rule 71(3) communication indicating its intent to grant a patent covering a novel preventative therapy targeting the serotonin 4 (5-HT4) receptor...

PRESS DIGEST-Wall Street Journal - April 7

Apr 6, 2026

April 7 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Anthropic is planning to invest $200 million in a new venture with major private-equity firms that aims to sell AI tools to their portfolio companies, continuing a push for business customers....